James J Bochnowski - Net Worth and Insider Trading

James J Bochnowski Net Worth

The estimated net worth of James J Bochnowski is at least $77 dollars as of 2024-11-13. James J Bochnowski is the Director of Jaguar Health Inc and owns about 71 shares of Jaguar Health Inc (JAGX) stock worth over $77. Details can be seen in James J Bochnowski's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James J Bochnowski has not made any transactions after 2021-06-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of James J Bochnowski

James J Bochnowski Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James J Bochnowski owns 8 companies in total, including Jaguar Health Inc (JAGX) , Senseonics Holdings Inc (SENS) , and TriVascular Technologies Inc (TRIV) among others .

Click here to see the complete history of James J Bochnowski’s form 4 insider trades.

Insider Ownership Summary of James J Bochnowski

Ticker	Comapny	Transaction Date	Type of Owner
JAGX	Jaguar Health Inc	2021-06-04	director
SENS	Senseonics Holdings Inc	2016-03-17	10 percent owner
TRIV	TriVascular Technologies Inc	2016-02-03	10 percent owner
		2014-10-01	10 percent owner
		2014-05-13	10 percent owner
		2013-11-13	10 percent owner
		2004-07-21	10 percent owner
		2003-07-18	director

James J Bochnowski Latest Holdings Summary

James J Bochnowski currently owns a total of 1 stock. James J Bochnowski owns 71 shares of Jaguar Health Inc (JAGX) as of June 4, 2021, with a value of $77.

Latest Holdings of James J Bochnowski

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
JAGX	Jaguar Health Inc	2021-06-04	71	1.09	77

Holding Weightings of James J Bochnowski

James J Bochnowski Form 4 Trading Tracker

According to the SEC Form 4 filings, James J Bochnowski has made a total of 1 transactions in Jaguar Health Inc (JAGX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Jaguar Health Inc is the sale of 0 shares on June 4, 2021, which brought James J Bochnowski around $777.

Insider Trading History of James J Bochnowski

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

James J Bochnowski Trading Performance

GuruFocus tracks the stock performance after each of James J Bochnowski's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James J Bochnowski is -34.81%. GuruFocus also compares James J Bochnowski's trading performance to market benchmark return within the same time period. The performance of stocks bought by James J Bochnowski within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how James J Bochnowski's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of James J Bochnowski

Average Return

Average return per transaction

Outperforming Transactions

0 out of 3 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-12.46
Relative Return to S&P 500(%)	-13.39

James J Bochnowski Ownership Network

Ownership Network List of James J Bochnowski

No Data

Ownership Network Relation of James J Bochnowski

James J Bochnowski Owned Company Details

What does Jaguar Health Inc do?

Who are the key executives at Jaguar Health Inc?

James J Bochnowski is the director of Jaguar Health Inc. Other key executives at Jaguar Health Inc include Chief Scientific Officer Pravin R Chaturvedi , director & CEO & President Lisa A Conte , and Chief Accounting Officer Carol R. Lizak .

Jaguar Health Inc (JAGX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Jaguar Health Inc (JAGX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Jaguar Health Inc (JAGX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Jaguar Health Inc (JAGX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Jaguar Health Inc Insider Transactions

No Available Data

What does Senseonics Holdings Inc do?

Who are the key executives at Senseonics Holdings Inc?

James J Bochnowski is the 10 percent owner of Senseonics Holdings Inc. Other key executives at Senseonics Holdings Inc include Chief Financial Officer Frederick T. Sullivan , VP Operations & Qual & Reg Mukul Jain , and VP Global Sales & Marketing Mirasol Panlilio .

Senseonics Holdings Inc (SENS) Insider Trades Summary

Over the past 18 months, James J Bochnowski made no insider transaction in Senseonics Holdings Inc (SENS). Other recent insider transactions involving Senseonics Holdings Inc (SENS) include a net purchase of 300,000 shares made by Douglas A Roeder , and a net sale of 30,889 shares made by Sharon Larkin .

In summary, during the past 3 months, insiders sold 0 shares of Senseonics Holdings Inc (SENS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 30,889 shares of Senseonics Holdings Inc (SENS) were sold and 300,000 shares were bought by its insiders, resulting in a net purchase of 269,111 shares.

Senseonics Holdings Inc (SENS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Senseonics Holdings Inc Insider Transactions

No Available Data

What does TriVascular Technologies Inc do?

Who are the key executives at TriVascular Technologies Inc?

James J Bochnowski is the 10 percent owner of TriVascular Technologies Inc. Other key executives at TriVascular Technologies Inc include 10 percent owner Krishna Kittu Kolluri , VP & Gen. Counsel and Secretary Kimberley A. Elting , and Chief Technology Officer Michael V. Chobotov .

TriVascular Technologies Inc (TRIV) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of TriVascular Technologies Inc (TRIV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TriVascular Technologies Inc (TRIV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

TriVascular Technologies Inc (TRIV)'s detailed insider trading history can be found in Insider Trading Tracker table.

TriVascular Technologies Inc Insider Transactions

No Available Data

What does Calithera Biosciences Inc do?

Who are the key executives at Calithera Biosciences Inc?

James J Bochnowski is the 10 percent owner of Calithera Biosciences Inc. Other key executives at Calithera Biosciences Inc include director & 10 percent owner Deepika Pakianathan , 10 percent owner Takeda Ventures, Inc. , and SR. VP & CLINICAL DEVELOPMENT Keith Orford .

Calithera Biosciences Inc (CALA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Calithera Biosciences Inc (CALA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Calithera Biosciences Inc (CALA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Calithera Biosciences Inc (CALA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Calithera Biosciences Inc Insider Transactions

No Available Data

What does Alder BioPharmaceuticals Inc do?

Who are the key executives at Alder BioPharmaceuticals Inc?

James J Bochnowski is the 10 percent owner of Alder BioPharmaceuticals Inc. Other key executives at Alder BioPharmaceuticals Inc include 10 percent owner H Lundbeck A S , Chief Medical Officer Paul Streck , and director & President and CEO Robert Azelby .

Alder BioPharmaceuticals Inc (ALDR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Alder BioPharmaceuticals Inc (ALDR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alder BioPharmaceuticals Inc (ALDR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Alder BioPharmaceuticals Inc (ALDR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Alder BioPharmaceuticals Inc Insider Transactions

No Available Data

What does Tandem Diabetes Care Inc do?

Who are the key executives at Tandem Diabetes Care Inc?

James J Bochnowski is the 10 percent owner of Tandem Diabetes Care Inc. Other key executives at Tandem Diabetes Care Inc include SVP & General Counsel Shannon Marie Hansen , Senior Vice President and CFO Leigh Vosseller , and GENERAL COUNSEL David B Berger .

Tandem Diabetes Care Inc (TNDM) Insider Trades Summary

Over the past 18 months, James J Bochnowski made no insider transaction in Tandem Diabetes Care Inc (TNDM). Other recent insider transactions involving Tandem Diabetes Care Inc (TNDM) include a net purchase of 10,000 shares made by Dick Allen , a net purchase of 6,200 shares made by Leigh Vosseller , and a net purchase of 3,000 shares made by Peyton R Howell .

In summary, during the past 3 months, insiders sold 0 shares of Tandem Diabetes Care Inc (TNDM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,000 shares of Tandem Diabetes Care Inc (TNDM) were sold and 27,135 shares were bought by its insiders, resulting in a net purchase of 22,135 shares.

Tandem Diabetes Care Inc (TNDM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tandem Diabetes Care Inc Insider Transactions

No Available Data

What does NeuroMetrix Inc do?

Who are the key executives at NeuroMetrix Inc?

James J Bochnowski is the 10 percent owner of NeuroMetrix Inc. Other key executives at NeuroMetrix Inc include Chief Financial Officer Thomas T Higgins , other: See Explanation in Footnotes Topline Capital Management, Llc , and 10 percent owner Topline Capital Partners, Lp .

NeuroMetrix Inc (NURO) Insider Trades Summary

Over the past 18 months, James J Bochnowski made no insider transaction in NeuroMetrix Inc (NURO). Other recent insider transactions involving NeuroMetrix Inc (NURO) include a net sale of 1,000 shares made by Joshua Horowitz ,

In summary, during the past 3 months, insiders sold 0 shares of NeuroMetrix Inc (NURO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,000 shares of NeuroMetrix Inc (NURO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,000 shares.

NeuroMetrix Inc (NURO)'s detailed insider trading history can be found in Insider Trading Tracker table.

NeuroMetrix Inc Insider Transactions

No Available Data

What does Natus Medical Inc do?

Who are the key executives at Natus Medical Inc?

James J Bochnowski is the director of Natus Medical Inc. Other key executives at Natus Medical Inc include Vice President Medical Affairs Chung Dong Chune Christopher , director & Sr. VP & CFO Jonathan Kennedy , and VP/GM Neurology Noll Austin Francis Iii .

Natus Medical Inc (NTUS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Natus Medical Inc (NTUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Natus Medical Inc (NTUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Natus Medical Inc (NTUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Natus Medical Inc Insider Transactions

No Available Data

James J Bochnowski Mailing Address

Above is the net worth, insider trading, and ownership report for James J Bochnowski. You might contact James J Bochnowski via mailing address: C/o Delphi Ventures, 160 Bovet Rd, Suite 408, San Mateo Ca 94402.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.